Synthesis and development of seven-membered constrained cyclic urea based PSMA inhibitors via RCM

Abstract

Prostate-specific membrane antigen (PSMA) biomarkers have been recognized as a viable tool for diagnosing prostate cancer (PCa). Herein, we focus on the development of cyclic PSMA inhibitors adopting a urea-based...